DARIANNA MAHECHA: Open Payments
NPI 1417519547 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 17 payments from 14 companies in 2025. Trend: 2023 $1,191 · 2024 $255 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Smith+Nephew, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| ConvaTec Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: REZDIFFRA, ENTYVIO, MAVYRET, Pico 14, DUPIXENT, IBSRELA, ESTEEM, VERQUVO.
Industry payments across NJ — which companies pay providers there.
